Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Endokrynol Pol ; 68(1): 35-41, 2017.
Article in English | MEDLINE | ID: mdl-26884296

ABSTRACT

INTRODUCTION: Paraoxonase 1 (PON1) polymorphisms have been largely involved in diabetes complications. The aim of the study is to evaluate the effects of PON1 polymorphisms (L55M and Q192R) on diabetic nephropathy (DN). MATERIAL AND METHODS: The study involved 116 children and adolescents with type 1 diabetes (T1D) and 91 healthy subjects. Albumin excretion rate (AER) was determined by immunoturbidimetry. PON1 activity was measured by a spectrophotometric method, and genotyping of PON1 gene was assessed by multiplex PCR followed by RFLP. RESULTS: PON1 activity was inversely correlated to AER (r = -0.245, p = 0.008). A significant decrease (p = 0.037) in PON1 activity was shown between patients with nephropathy and those without (162 [57-618] vs. 316 [37-788] IU/L, respectively). The distribution of AER was, for L55M polymorphism MM > LM > LL (p = 0.002), and for Q192R polymorphism QQ > QR > RR (p < 0.001). The opposite distribution was noted for PON 1 activity (p < 0.001). LMQQ and MMQQ haplotypes seem to increase AER (p = 0.004, p = 0.003, respectively) and to reduce PON1 activity (p = 0.011, p = 0.052, respectively) in youths with T1D. However, LLRR haplotype seems to have the opposite effect. CONCLUSIONS: This study demonstrated that PON1 polymorphisms L55M and Q192R seem to be genetic markers involved in the development of DN in T1D. (Endokrynol Pol 2017; 68 (1): 35-41).


Subject(s)
Aryldialkylphosphatase/genetics , Diabetes Mellitus, Type 1/enzymology , Diabetic Nephropathies/enzymology , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Adolescent , Aryldialkylphosphatase/metabolism , Child , Child, Preschool , Diabetes Mellitus, Type 1/genetics , Diabetic Nephropathies/genetics , Female , Genetic Association Studies , Haplotypes , Humans , Infant , Male , Young Adult
2.
J Clin Lipidol ; 8(3): 249-55, 2014.
Article in English | MEDLINE | ID: mdl-24793345

ABSTRACT

BACKGROUND: Only a few studies have focused on the possible modulatory role of paraoxonase 1 (PON1) polymorphisms in lipid profiles, especially in children and in adolescents with type 1 diabetes (T1D). OBJECTIVE: We propose to study the association between PON1 polymorphisms (PON1-55 and PON1-192) and a lipid profile in a young Tunisian population with T1D. METHODS: The study compared 122 children and adolescents with T1D with 97 controls. Genomic DNA was collected from 116 patients and 91 controls. Lipid parameters were determined by automated methods. PON1 activity was measured by a spectrophotometric method and genotyping of the PON1 gene was assessed by multiplex polymerase chain reaction followed by restriction fragment-length polymorphism. RESULTS: A significant increase in total cholesterol, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol (LDL-C), apolipoprotein B (ApoB), and lipoprotein (a) (Lp(a)) and a significant decrease in apolipoprotein A1 (ApoA1), ApoA1/ApoB ratio, and PON1 activity/HDL-C ratio were observed in children with T1D compared with controls. In the LLQR haplotype, the group with diabetes showed significantly higher values of total cholesterol, LDL-C, apoB, Lp(a), and apoA1/apoB ratio compared with the control group. Those with diabetes with the LLQQ haplotype showed a significant decrease in LDL-C and Lp(a) compared with controls (P < .0001). CONCLUSION: PON1 polymorphisms (PON1-55 and PON1-192) seem to be involved in the altering the lipid profile in T1D. The LLQR haplotype provided an atherogenic lipid profile in children with T1D compared with controls. LLQQ haplotype seemed to have a protective effect against the increase in LDL-C and Lp(a) that are heavily involved in the development of cardiovascular diseases.


Subject(s)
Aryldialkylphosphatase/genetics , Diabetes Mellitus, Type 1/genetics , Lipid Metabolism Disorders/genetics , Adolescent , Adult , Apolipoproteins/metabolism , Aryldialkylphosphatase/metabolism , Child , Cholesterol/metabolism , Female , Gene Frequency , Genotype , Haplotypes , Humans , Male , Polymorphism, Genetic , Spectrometry, Fluorescence , Tunisia , Young Adult
3.
Biol Trace Elem Res ; 148(1): 76-82, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22351102

ABSTRACT

Erythrocytes are a convenient model to understand the subsequent oxidative deterioration of biological macromolecules in metal toxicities. The present study examined the variation of hematoxic and genotoxic parameters following subchronic exposure of mercuric chloride via drinking water and their possible association with oxidative stress. Male rats were exposed to 50 ppm (HG1) and 100 ppm (HG2) of mercuric chloride daily for 90 days. A significant dose-dependent decrease was observed in red blood cell count, hemoglobin, hematocrit, and mean cell hemoglobin concentration in treated groups (HG1 and HG2) compared with controls. A significant dose-dependent increase was observed in lipid peroxidation; therefore, a significant variation was found in the antioxidant enzyme activities, such as superoxide dismutase, catalase, and glutathione peroxidase. Interestingly, mercuric chloride treatment showed a significant dose-dependent increase in frequency of total chromosomal aberration and in percentage of aberrant bone marrow metaphase of treated groups (p < 0.01). The oxidative stress induced by mercury treatment may be the major cause for chromosomal aberration as free radicals lead to DNA damage. These data will be useful in screening the antioxidant activities of natural products, which may be specific to the bone marrow tissue.


Subject(s)
Anti-Infective Agents, Local/adverse effects , Bone Marrow/metabolism , DNA Damage , Hemolytic Agents/adverse effects , Mercuric Chloride/adverse effects , Oxidative Stress/drug effects , Animals , Anti-Infective Agents, Local/pharmacology , Antioxidants/metabolism , Bone Marrow/pathology , Chromosome Aberrations/drug effects , Dose-Response Relationship, Drug , Erythrocyte Count , Free Radicals/metabolism , Hemoglobins/metabolism , Hemolytic Agents/pharmacology , Lipid Peroxidation/drug effects , Male , Mercuric Chloride/pharmacology , Oxidoreductases/metabolism , Rats , Rats, Wistar , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL